Source:http://linkedlifedata.com/resource/pubmed/id/18417479
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
23
|
pubmed:dateCreated |
2008-6-2
|
pubmed:abstractText |
MicroRNAs (miRNAs) are small non-protein-coding RNAs that function as negative gene expression regulators. In the present study, we investigated miRNAs role in endothelial cell response to hypoxia. We found that the expression of miR-210 progressively increased upon exposure to hypoxia. miR-210 overexpression in normoxic endothelial cells stimulated the formation of capillary-like structures on Matrigel and vascular endothelial growth factor-driven cell migration. Conversely, miR-210 blockade via anti-miRNA transfection inhibited the formation of capillary-like structures stimulated by hypoxia and decreased cell migration in response to vascular endothelial growth factor. miR-210 overexpression did not affect endothelial cell growth in both normoxia and hypoxia. However, anti-miR-210 transfection inhibited cell growth and induced apoptosis, in both normoxia and hypoxia. We determined that one relevant target of miR-210 in hypoxia was Ephrin-A3 since miR-210 was necessary and sufficient to down-modulate its expression. Moreover, luciferase reporter assays showed that Ephrin-A3 was a direct target of miR-210. Ephrin-A3 modulation by miR-210 had significant functional consequences; indeed, the expression of an Ephrin-A3 allele that is not targeted by miR-210 prevented miR-210-mediated stimulation of both tubulogenesis and chemotaxis. We conclude that miR-210 up-regulation is a crucial element of endothelial cell response to hypoxia, affecting cell survival, migration, and differentiation.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0021-9258
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
6
|
pubmed:volume |
283
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
15878-83
|
pubmed:meshHeading |
pubmed-meshheading:18417479-Apoptosis,
pubmed-meshheading:18417479-Cell Differentiation,
pubmed-meshheading:18417479-Cell Hypoxia,
pubmed-meshheading:18417479-Cell Survival,
pubmed-meshheading:18417479-Cells, Cultured,
pubmed-meshheading:18417479-Chemotaxis,
pubmed-meshheading:18417479-Endothelial Cells,
pubmed-meshheading:18417479-Ephrin-A3,
pubmed-meshheading:18417479-Gene Expression Regulation,
pubmed-meshheading:18417479-Humans,
pubmed-meshheading:18417479-MicroRNAs,
pubmed-meshheading:18417479-RNA, Antisense,
pubmed-meshheading:18417479-Transfection,
pubmed-meshheading:18417479-Vascular Endothelial Growth Factor A
|
pubmed:year |
2008
|
pubmed:articleTitle |
MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3.
|
pubmed:affiliation |
Laboratorio di Patologia Vascolare, Istituto Dermopatico dell'Immacolata, IRCCS, 00167 Rome.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|